Add BrightSurf on Google Email

A new era of mitochondrial genome editing has begun

Scientists have successfully developed a gene-editing platform called TALED that can perform A-to-G base conversion in mitochondria, the final missing piece of the puzzle in gene-editing technology. This breakthrough has significant implications for treating previously incurable genetic diseases caused by mutations in mitochondrial DNA.

SourceInstitute for Basic Science·JournalCell·TypeExperimental study·DateApr 25, 2022

A small switch with a big impact

Scientists have discovered that tiny point mutations in a gene can modify T cells to be less aggressive, leading to reduced inflammation and autoimmune responses. This finding has potential implications for stem cell transplantation, where T-cell transfusion is used to prevent severe side effects.

SourceUniversity of Würzburg·JournalJournal of Experimental Medicine·DateOct 5, 2020